Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,089 | 26 | 1,100 | 3,252 | 17,911 |
| Inventories | 17,209 | 15,339 | 14,381 | 8,269 | N/A |
| TOTAL | $24,611 | $18,375 | $18,327 | $14,221 | $28,006 |
| Non-Current Assets | |||||
| Investments And Advances | 38 | 38 | 38 | 38 | 38 |
| Intangibles | 9,347 | 9,347 | 9,347 | 9,347 | 9,347 |
| Other Non-Current Assets | 93,681 | 93,722 | 92,991 | 93,046 | 59,700 |
| TOTAL | $103,066 | $103,107 | $102,376 | $102,431 | $69,085 |
| Total Assets | $127,677 | $121,481 | $120,704 | $116,652 | $97,091 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,094 | 9,368 | 7,364 | 4,927 | 1,663 |
| Accrued Expenses | 12,234 | 11,963 | 8,837 | 2,246 | 2,253 |
| Other current liabilities | 28,400 | 28,400 | 28,400 | 28,400 | N/A |
| TOTAL | $51,843 | $49,877 | $44,806 | $35,815 | $4,152 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,181 | 1,382 | 513 | 21 | 84 |
| TOTAL | $8,274 | $8,029 | $6,978 | $6,735 | $6,654 |
| Total Liabilities | $60,116 | $57,906 | $51,784 | $42,550 | $10,806 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,012 | 10,290 | 8,593 | 7,727 | 7,229 |
| Common Shares | 15 | 9 | 8 | 7 | 181 |
| Retained earnings | -230,845 | -222,055 | -211,139 | -201,370 | -190,580 |
| Other shareholders' equity | 2,502 | 2,916 | 3,512 | 4,024 | 600 |
| TOTAL | $67,561 | $63,576 | $68,920 | $74,102 | $86,284 |
| Total Liabilities And Equity | $127,677 | $121,481 | $120,704 | $116,652 | $97,091 |